InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Girgenti Steven. Director active across 2 companies, notably bioAffinity Technologies, Inc.. In total, 11 reports have been recorded. Activity tracked since 6 September 2022. The latest transaction was disclosed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
GIRGENTI STEVEN is a declarant linked to bioAffinity Technologies, Inc., where he is Executive Chairman, and to Vycor Medical INC, where he is Director. He has 11 filings in total, with all 11 included in the sampled set, and the recent filings are attribution filings spanning 2016-01-08 to 2025-01-14. The reported buy and sell volumes for the tracked recent filings are 0 EUR each.